Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality may help COPD patients breathe easier during exercise

NCT ID NCT06811402

Symptom relief Sponsor: Fondation Hôpital Saint-Joseph Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time

Summary

This trial tests whether wearing a virtual reality headset during pulmonary rehabilitation can reduce shortness of breath and improve exercise tolerance in people with chronic respiratory disease like COPD. Participants will do a cycling exercise test twice, once with VR and once without, to compare how long they can sustain effort. The goal is to see if VR's distraction effect can help patients push through the discomfort that often limits their activity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual reality during pulmonary rehabilitation
What this could lead to
If VR helps, it could make pulmonary rehabilitation more tolerable and effective, improving exercise capacity and quality of life for people with chronic respiratory disease.
What could go wrong
This is a small early trial with 26 participants, and the distraction effect of VR may not translate into meaningful physical gains. VR may also cause discomfort or motion sickness in some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 26 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient aged 18 years or older * Patient with a chronic respiratory disease requiring pulmonary rehabilitation * Patient with dyspnea assessed as mMRC ≥ 0 (Annex 3) * Patient undergoing pulmonary rehabilitation at the Paris Saint-Joseph Hospital * Patient affiliated with a health insurance plan * French-speaking patient * Patient who has provided informed, explicit, and voluntary oral consent Exclusion Criteria: * Contraindications for an endurance reconditioning program (neurodegenerative diseases, severe neurological deficits, unstable cardiovascular diseases) * History of motion sickness, vertigo, vestibular impairment, labyrinthitis * History of seizures or other neurological or psychiatric comorbidities * Severe visual impairments * Patient already included in a Type 1 interventional research protocol (RIPH1) * Patient under guardianship or curatorship * Patient deprived of liberty * Patient under legal protection * Pregnant or breastfeeding patient

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive pulmonary disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hôpital Paris Saint Joseph

    Paris, Paris, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.